Catherine Tsilfidis

Catherine Tsilfidis

Company: Ottawa Hospital Research Institute

Job title: Senior Scientist


Senior Scientist, Ottawa Hospital Research Institute
Don and Joy Maclaren Chair for Vision Research
Associate Professor, Departments of Ophthalmology and Cellular and Molecular Medicine, University of Ottawa


XIAP Anti-Apoptotic Gene Therapy for the Treatment of Glaucoma 1:50 pm

Using gene therapy to target apoptosis of the cell (the final endpoint for many ocular diseases) is a general strategy that doesn't target a specific mutation The X-linked inhibitor of apoptosis (XIAP) is able to block apoptosis by preventing caspase activation, but can also block necroptosis and inflammasome formation XIAP gene therapy is effective in…Read more

day: Preclinical 4

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.